NSECertificate under SEBI (Depositories and Participants) Regulations, 201810 Jul 2026 · 10 Jul 2026, 10:14 am
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Sudeep Pharma Limited · SUDEEPPHRM
✦ AI SummaryRegulatory
Sudeep Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming that all shares are held in electronic mode only.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sudeep Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Attachments (1)
📄pdf
Download →
SUDEEPPHARMALIMITED_10072026101358_Submission_of_Certificate_under_Regulation_74_5__of_SEBI.pdf
View document text
Date: 10th July 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, C-1, Block G Bandra Kurla Phiroze Jeejeebhoy Towers Dalal Street,
Complex, Bandra (E), Mumbai – 400051 Mumbai – 400001
Scrip Symbol- SUDEEPPHRM Scrip Code: 544619
Sub: Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations,
2018 for the quarter ended on 30th June 2026
Ref: Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
Dear Sir/Ma’am,
We enclose herewith Certificate under Regulation 74(5) of SEBI (Depositories and Participants)
Regulations, 2018, issued by the Company’s Registrar and Share Transfer Agent, M/s. MUFG
Intime India Private Limited for the quarter ended on 30th June 2026.
Kindly take the same on record.
Thanking you,
For Sudeep Pharma Limited
Dimple Mehta
Company Secretary & Compliance Officer
M. No.: F13184
ENCL: A/a
CIN: L24231GJ1989PLC013141
Registered Office: 129/1/A, G.I.D.C. Estate Nandesari, Baroda-391340, Gujarat, India.
Phone No.: +91 265 2840656, 7624095107
Corporate Office: 601, 602, 6th Floor, Sears Towers-2, Gotri-Sevasi Road, Sevasi, Vadodara-390021, Gujarat,
India Website: www.sudeepgroup.com, Email ID: mail@sudeepgroup.com
MUFG Intime India Private Limited
(Formerly Link Intime India Private Limited)
CIN: U67190MH1999PTC118368
Registered Address:
C-101, Embassy 247, L.B.S. Marg,
Vikhroli (West), Mumbai - 400 083
Tel: +91 22 4918 6000
Email:Investor.helpdesk@in.mpms.mufg.com
Website: https://in.mpms.mufg.com
Ref. No. CSC/SUDEEP/2026
9th July 2026
Sudeep Pharma Limited
129/1/A, G.I.D.C. Estate,
Nandesari,
Vadodara – 391340,,
Gujarat, India
Kind Attn : Ms. Dimple Mehta
Dear Madam,
Subject: Confirmation Certificate in the matter of Regulation 74(5) of Securities and
Exchange Board of India (Depositories and Participants) Regulations, 2018.
We hereby confirm that during the quarter ended 30th June 2026 we have not received any demat request
for processing as all shares of Sudeep Pharma Limited are held in electronic mode only.
Kindly take note of the same in your records.
Thanking you,
Yours faithfully,
For MUFG INTIME INDIA PRIVATE LIMITED
(Formerly Link Intime India Private Limited)
(Damodar Kambli)
Assistant Vice President
MUFG Intime India Private Limited
A part of MUFG Corporate Markets, a division of MUFG Pension & Market Services